Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × camrelizumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 40 Stomach Neoplasms 22 Esophageal Neoplasms 20 Esophageal Squamous Cell Carcinoma 19 Colorectal Neoplasms 12 Pancreatic Neoplasms 9 Liver Neoplasms 6 Cholangiocarcinoma 6 Biliary Tract Neoplasms 5 Advanced Gastric Cancer 5 Locally Advanced Gastric Cancer 4 Rectal Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Metastatic Gastric Adenocarcinoma 2 Locally Advanced Rectal Cancer 2 Liver Diseases 2 Gastrointestinal Neoplasms 2 Esophageal Diseases 2 Digestive System Neoplasms 2 Colonic Neoplasms 2 Advanced Gastric Adenocarcinoma 2 Unresectable Gallbladder Cancer 1 Turcot syndrome 1 Stomach Diseases 1 Stage IV Gastric Cancer With Metastasis 1 Second Line Treatment of Gastric Cancer 1 SHR-1210 1 Recurrence 1 Rectal Cancer Patients 1

Interventions

pembrolizumab 5 Nivolumab 5 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 danvatirsen 1 camrelizumab 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Irinotecan 1 Interleukin-2 1 Immunoglobulin G 1 IMM-101 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06215677 2025-09-05

NITDC

Peking Union Medical College Hospital

Phase NA Recruiting

Gastrointestinal

Turcot syndrome, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡